Bio-Rad Laboratories (BIO) Net Cash Flow (QoQ) (2009 - 2026)
Bio-Rad Laboratories (BIO) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn |
| 10 | Bio-Rad Laboratories | 8.61 Bn | 7.05 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121.72% |
| Dec 31, 2025 | 427.56% |
| Sep 30, 2025 | 118.79% |
| Jun 30, 2025 | -485.19% |
| Mar 31, 2025 | -48.00% |
| Dec 31, 2024 | 467.23% |
| Sep 30, 2024 | 139.80% |
| Jun 30, 2024 | -211.99% |
| Mar 31, 2024 | 156.35% |
| Dec 31, 2023 | -176.92% |
| Sep 30, 2023 | 180.34% |
| Jun 30, 2023 | -339.94% |
| Mar 31, 2023 | 148.75% |
| Dec 31, 2022 | 23.96% |
| Sep 30, 2022 | 59.44% |
| Jun 30, 2022 | -165.46% |
| Mar 31, 2022 | 182.84% |
| Dec 31, 2021 | -393.70% |
| Sep 30, 2021 | 133.18% |
| Jun 30, 2021 | 219.21% |